Regulation of TNFR1 and CD95 signalling by receptor compartmentalization

Nature Reviews Molecular Cell Biology

Volumn 9, Issue 8, 2008, Pages 655-662

  Schütze, Stefan ^a   Tchikov, Vladimir ^a   Schneider Brachert, Wulf ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR 1;

APOPTOSIS; CELL COMPARTMENTALIZATION; CELL DEATH; CELL SURVIVAL; ENDOCYTOSIS; HUMAN; NOTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL COMPARTMENTATION; HUMANS; MODELS, BIOLOGICAL; PROTEIN TRANSPORT; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION;

EID: 47749089820     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm2430     Document Type: Note

References (73)

1. McPherson, P. S., Kay, B. K. & Hussain, N. K. Signaling on the endocytic pathway. Traffic 2001. 2, 375-384 (2001).
2. Sorkin, A. & Von Zastrow, M. Signal transduction and endocytosis: close encounters of many kinds. Nature Rev. Mol. Cell Biol. 3, 600-614 (2002).
3. Teis, D. & Huber, L. A. The odd couple: signal transduction and endocytosis. Cell Mol. Life Sci. 60, 2020-2033 (2003).
4. Miaczynska, M., Pelkmans, L. & Zerial, M. Not just a sink: endosomes in control of signal transduction. Curr. Opin. Cell Biol. 16, 400-406 (2004).
5. Le Roy, C. & Wrana, J. L. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nature Rev. Mol. Cell Biol. 6, 112-126 (2005).
6. Mayor, S. & Pagano, R. E. Pathways of clathrinin-dependent endocytosis. Nature Rev. Mol. Cell Biol. 8, 603-612 (2007).
7. Hsu, H., Shu, H. B., Pan, M. G. & Goeddel, D. V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308 (1996).
8. Kischkel, F. C. et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14, 5579-5588 (1995).
9. Scaffidi, C., Medema, J. P., Krammer, P. H. & Peter, M. E. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J. Biol. Chem. 272, 26953-26958 (1997).
10. Medema, J. P. et al. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16, 2794-2804 (1997).
11. Yeh, W. C. et al. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7, 715-725 (1997).
12. Lee, S. Y. et al. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity 7, 703-713 (1997).
13. Grech, A. P. et al. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-κB activation in mature B cells. Immunity 21, 629-642 (2004).
14. Harper, N., Hughes, M., MacFarlane, M. & Cohen, G. M. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. J. Biol. Chem. 278, 25534-25541 (2003).
15. Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181-190 (2003).
16. Locksley, R. M., Killeen, N. & Lenardo, M. J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487-501 (2001).
17. Wajant, H., Pfizenmaier, K. & Scheurich, P. Tumor necrosis factor signaling. Cell Death. Differ. 10, 45-65 (2003).
18. Mosselmans, R., Hepburn, A., Dumont, J. E., Fiers, W. & Galand, P. Endocytic pathway of recombinant murine tumor necrosis factor in L-929 cells. J. Immunol. 141, 3096-3100 (1988).
19. Bradley, J. R., Johnson, D. R. & Pober, J. S. Four different classes of inhibitors of receptor-mediated endocytosis decrease tumor necrosis factor-induced gene expression in human endothelial cells. J. Immunol. 150, 5544-5555 (1993).
20. Schütze, S. et al. Inhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling. J. Biol. Chem. 274, 10203-10212 (1999).
21. Schneider-Brachert, W. et al. Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21, 415-428 (2004).
22. Schneider-Brachert, W. et al. Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism. J. Clin. Invest. 116, 2901-2913 (2006).
23. Kull, F. C. Jr. & Cuatrecasas, P. Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum. Cancer Res. 41, 4885-4890 (1981).
24. Watanabe, N. et al. Continuous internalization of tumor necrosis factor receptors in a human myosarcoma cell line. J. Biol. Chem. 263, 10262-10266 (1988).
25. Pastorino, J. G. et al. The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J. Biol. Chem. 271, 29792-29798 (1996).
26. Wiegmann, K., Schütze, S., Machleidt, T., Witte, D. & Krönke, M. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78, 1005-1015 (1994).
27. Lin, T. et al. Role of acidic sphingomyelinase in Fas/CD95-mediated cell death. J. Biol. Chem. 275, 8657-8663 (2000).
28. Morales, A., Lee, H., Goni, F. M., Kolesnick, R. & Fernandez-Checa, J. C. Sphingolipids and cell death. Apoptosis 12, 923-939 (2007).
29. Manthey, C. L. & Schuchman, E. H. Acid sphingomyelinase-derived ceramide is not required for inflammatory cytokine signalling in murine macrophages. Cytokine 10, 654-661 (1998).
30. Nix, M. & Stoffel, W. Perturbation of membrane microdomains reduces mitogenic signaling and increases susceptibility to apoptosis after T cell receptor stimulation. Cell Death. Differ. 7, 413-424 (2000).
31. Adam, D., Wiegmann, K., Adam-Klages, S., Ruff, A. & Krönke, M. A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway. J. Biol. Chem. 271, 14617-14622 (1996).
32. Adam-Klages, S. et al. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86, 937-947 (1996).
33. Boone, E., Vandevoorde, V., De Wilde, G. & Haegeman, G. Activation of p42/p44 mitogen-activated protein kinases (MAPK) and p38 MAPK by tumor necrosis factor (TNF) is mediated through the death domain of the 55-kDa TNF receptor. FEBS Lett. 441, 275-280 (1998).
34. Schwandner, R., Wiegmann, K., Bernardo, K., Kreder, D. & Krönke, M. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J. Biol. Chem. 273, 5916-5922 (1998).
35. Wiegmann, K. et al. Requirement of FADD for tumor necrosis factor-induced activation of acid sphingomyelinase. J. Biol. Chem. 274, 5267-5270 (1999).
36. Monney, L. et al. Role of an acidic compartment in tumor-necrosis-factor-α-induced production of ceramide, activation of caspase-3 and apoptosis. Eur. J. Biochem. 251, 295-303 (1998).
37. Garcia-Ruiz, C. et al. Defective TNF-α-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J. Clin. Invest. 111, 197-208 (2003).
38. Heinrich, M. et al. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death. Differ. 11, 550-563 (2004).
39. Cifone, M. G. et al. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med. 180, 1547-1552 (1994).
40. Herr, I., Wilhelm, D., Bohler, T., Angel, P. & Debatin, K. M. Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J. 16, 6200-6208 (1997).
41. De Maria, R., Rippo, M. R., Schuchman, E. H. & Testi, R. Acidic sphingomyelinase (ASM) is necessary for Fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells. J. Exp. Med. 187, 897-902 (1998).
42. Brenner, B. et al. Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspases. Cell Death. Differ. 5, 29-37 (1998).
43. Dumitru, C. A. & Gulbins, E. TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis. Oncogene. 25, 5612-5625 (2006).
44. Thon, L., Mathieu, S., Kabelitz, D. & Adam, D. The murine TRAIL receptor signals caspase-independent cell death through ceramide. Exp. Cell Res. 312, 3808-3821 (2006).
45. Woo, C. H. et al. Inhibition of receptor internalization attenuates the TNFα-induced ROS generation in nonphagocytic cells. Biochem. Biophys. Res. Commun. 351, 972-978 (2006).
46. Heinrich, M. et al. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J. 18, 5252-5263 (1999).
47. Chen, G. & Goeddel, D. V. TNF-R1 signaling: a beautiful pathway. Science 296, 1634-1635 (2002).
48. Neumeyer, J. et al. TNF-receptor I defective in internalization allows for cell death through activation of neutral sphingomyelinase. Exp. Cell Res. 312, 2142-2153 (2006).
49. Schütze, S. & Tchikov, V. in Programmed Cell Death Part A Volume 442 Ch. 5 (eds Khosravi-Far, R. et al.) (Academic Press, in the press).
50. Stanger, B. Z., Leder, P., Lee, T. H., Kim, E. & Seed, B. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81, 513-523 (1995).
51. Hsu, H., Huang, J., Shu, H. B., Baichwal, V. & Goeddel, D. V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387-396 (1996).
52. Zheng, L. et al. Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1. Mol. Cell. Biol. 26, 3505-3513 (2006).
53. Jin, Z. & El Deiry, W. S. Distinct signaling pathways in TRAIL- versus tumor necrosis factor-induced apoptosis. Mol. Cell. Biol. 26, 8136-8148 (2006).
54. Kelliher, M. A. et al. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8, 297-303 (1998).
55. Devin, A. et al. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12, 419-429 (2000).
56. Liao, W. et al. CARP-2 is an endosome-associated ubiquitin protein ligase for RIP and regulates TNF-induced NF-B activation. Current Biology 18, 641-649 (2008).
57. Li-Weber, M. & Krammer, P. H. Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system. Semin. Immunol. 15, 145-157 (2003).
58. Peter, M. E. et al. The CD95 receptor: apoptosis revisited. Cell 129, 447-450 (2007).
59. Algeciras-Schimnich, A. et al. Molecular ordering of the initial signaling events of CD95. Mol. Cell. Biol. 22, 207-220 (2002).
60. Feig, C., Tchikov, V., Schütze, S. & Peter, M. E. Palmitoylation of CD95 facilitates formation of SDSstable receptor aggregates that initiate apoptosis signaling. EMBO J. 26, 221-231 (2007).
61. Siegel, R. M. et al. SPOTS: signaling protein oligomeric transduction structures are early mediators of death receptor-induced apoptosis at the plasma membrane. J. Cell Biol. 167, 735-744 (2004).
62. Lee, K. H. et al. The role of receptor internalization in CD95 signaling. EMBO J. 24, 1009-1023 (2006).
63. Eramo, A. et al. CD95 death-inducing signaling complex formation and internalization occur in lipid rafts of type I and type II cells. Eur. J. Immunol. 34, 1930-1940 (2004).
64. Chakrabandhu, K. et al. Palmitoylation is required for efficient Fas cell death signaling. EMBO J. 26, 209-220 (2007).
65. Parlato, S. et al. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J. 19, 5123-5134 (2000).
66. Koncz, G., Kerekes, K., Chakrabandhu, K. & Hueber, A. O. Regulating Vav1 phosphorylation by the SHP-1 tyrosine phosphatase is a fine-tuning mechanism for the negative regulation of DISC formation and Fas-mediated cell death signaling. Cell Death. Differ. 15, 494-503 (2007).
67. Barnhart, B. C. et al. CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J. 23, 3175-3185 (2004).
68. Ahn, J. H. et al. Non-apoptotic signaling pathways activated by soluble Fas ligand in serum-starved human fibroblasts. Mitogen-activated protein kinases and NF-κB-dependent gene expression. J. Biol. Chem. 276, 47100-47106 (2001).
69. Kataoka, T. et al. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways. Curr. Biol. 10, 640-648 (2000).
70. Golks, A., Brenner, D., Krammer, P. H. & Lavrik, I. N. The c-FLIP-NH2 terminus (p22-FLIP) induces NF-κB activation. J. Exp. Med. 203, 1295-1305 (2006).
71. Smotrys, J. E. & Linder, M. E. Palmitoylation of intracellular signaling proteins: regulation and function. Annu. Rev. Biochem. 73, 559-587 (2004).
72. Austin, C. D. et al. Death-receptor activation halts clathrin-dependent endocytosis. Proc. Natl Acad. Sci. USA. 103, 10283-10288 (2006).
73. Kohlhaas, S. L., Craxton, A., Sun, X. M., Pinkoski, M. J. & Cohen, G. M. Receptor-mediated endocytosis is not required for TRAIL-induced apoptosis. J. Biol. Chem. 282, 12831-12841 (2007).